AsianScientist (Dec. 19, 2016) – NovogeneAIT, a new joint venture between commercial genomics solutions provider Novogene and Singaporean biotechnology company AITbiotech Pte Ltd, will establish a joint whole genome sequencing (WGS) center at Biopolis, Singapore.
The new center will provide Illumina HiSeq X-based whole genome sequencing and bioinformatics analysis of human, plant and animal samples for biomedical and agricultural researchers. A major portion of the center’s sequencing capability will be devoted to support public research projects and empower super scale sequencing initiatives in Singapore and the region.
In addition, NovogeneAIT will collaborate with the Genome Institute of Singapore (GIS) to develop new applications of next-generation sequencing, such as WGS solutions for cancer diagnosis and stratified cancer treatment.
“We are delighted to work with a local biotech company.,” said Professor Ng Huck Hui, executive director of GIS. “Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies.”
Source: A*STAR; Photo: Novogene/AIT Biotech/A*STAR.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.